<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-10-19" modified="2020-10-07" version="216">
<accession>Q92831</accession>
<accession>Q6NSK1</accession>
<name>KAT2B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Histone acetyltransferase KAT2B</fullName>
<ecNumber evidence="35">2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="40">Histone acetyltransferase PCAF</fullName>
<shortName evidence="40">Histone acetylase PCAF</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="41">Lysine acetyltransferase 2B</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="40">P300/CBP-associated factor</fullName>
<shortName evidence="40">P/CAF</shortName>
</alternativeName>
<alternativeName>
<fullName>Spermidine acetyltransferase KAT2B</fullName>
<ecNumber evidence="30">2.3.1.57</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="41 45">KAT2B</name>
<name type="synonym" evidence="40">PCAF</name>
</gene>
<organism evidence="44">
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1" evidence="42">
<citation type="journal article" date="1996" name="Nature" volume="382" first="319" last="324">
<title>A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.</title>
<authorList>
<person name="Yang X.-J."/>
<person name="Ogryzko V.V."/>
<person name="Nishikawa J."/>
<person name="Howard B.H."/>
<person name="Nakatani Y."/>
</authorList>
<dbReference type="PubMed" id="8684459"/>
<dbReference type="DOI" id="10.1038/382319a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH EP300 AND CREBBP</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2" evidence="42">
<citation type="submission" date="1999-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Nakatani Y."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1996" name="Cell" volume="87" first="953" last="959">
<title>The transcriptional coactivators p300 and CBP are histone acetyltransferases.</title>
<authorList>
<person name="Ogryzko V.V."/>
<person name="Schiltz R.L."/>
<person name="Russanova V."/>
<person name="Howard B.H."/>
<person name="Nakatani Y."/>
</authorList>
<dbReference type="PubMed" id="8945521"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)82001-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27629" last="27634">
<title>TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.</title>
<authorList>
<person name="Takeshita A."/>
<person name="Cardona G.R."/>
<person name="Koibuchi N."/>
<person name="Suen C.-S."/>
<person name="Chin W.W."/>
</authorList>
<dbReference type="PubMed" id="9346901"/>
<dbReference type="DOI" id="10.1074/jbc.272.44.27629"/>
</citation>
<scope>INTERACTION WITH NCOA3</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Nature" volume="389" first="194" last="198">
<title>Steroid receptor coactivator-1 is a histone acetyltransferase.</title>
<authorList>
<person name="Spencer T.E."/>
<person name="Jenster G."/>
<person name="Burcin M.M."/>
<person name="Allis C.D."/>
<person name="Zhou J."/>
<person name="Mizzen C.A."/>
<person name="McKenna N.J."/>
<person name="Onate S.A."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.-J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="9296499"/>
<dbReference type="DOI" id="10.1038/38304"/>
</citation>
<scope>INTERACTION WITH NCOA1</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="9855" last="9860">
<title>Acetylation and modulation of erythroid Krueppel-like factor (EKLF) activity by interaction with histone acetyltransferases.</title>
<authorList>
<person name="Zhang W."/>
<person name="Bieker J.J."/>
</authorList>
<dbReference type="PubMed" id="9707565"/>
<dbReference type="DOI" id="10.1073/pnas.95.17.9855"/>
</citation>
<scope>INTERACTION WITH KLF1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="EMBO J." volume="19" first="662" last="671">
<title>Regulation of E2F1 activity by acetylation.</title>
<authorList>
<person name="Martinez-Balbas M.A."/>
<person name="Bauer U.M."/>
<person name="Nielsen S.J."/>
<person name="Brehm A."/>
<person name="Kouzarides T."/>
</authorList>
<dbReference type="PubMed" id="10675335"/>
<dbReference type="DOI" id="10.1093/emboj/19.4.662"/>
</citation>
<scope>INTERACTION WITH E2F1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="11852" last="11857">
<title>p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex.</title>
<authorList>
<person name="Harrod R."/>
<person name="Kuo Y.-L."/>
<person name="Tang Y."/>
<person name="Yao Y."/>
<person name="Vassilev A."/>
<person name="Nakatani Y."/>
<person name="Giam C.-Z."/>
</authorList>
<dbReference type="PubMed" id="10766811"/>
<dbReference type="DOI" id="10.1074/jbc.275.16.11852"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="44936" last="44943">
<title>Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles.</title>
<authorList>
<person name="Chakraborty S."/>
<person name="Senyuk V."/>
<person name="Sitailo S."/>
<person name="Chi Y."/>
<person name="Nucifora G."/>
</authorList>
<dbReference type="PubMed" id="11568182"/>
<dbReference type="DOI" id="10.1074/jbc.m106733200"/>
</citation>
<scope>INTERACTION WITH MECOM</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="6811" last="6819">
<title>Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF.</title>
<authorList>
<person name="Bres V."/>
<person name="Tagami H."/>
<person name="Peloponese J.-M."/>
<person name="Loret E."/>
<person name="Jeang K.-T."/>
<person name="Nakatani Y."/>
<person name="Emiliani S."/>
<person name="Benkirane M."/>
<person name="Kiernan R.E."/>
</authorList>
<dbReference type="PubMed" id="12486002"/>
<dbReference type="DOI" id="10.1093/emboj/cdf669"/>
</citation>
<scope>INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7091" last="7097">
<title>Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.</title>
<authorList>
<person name="Curtis A.M."/>
<person name="Seo S.B."/>
<person name="Westgate E.J."/>
<person name="Rudic R.D."/>
<person name="Smyth E.M."/>
<person name="Chakravarti D."/>
<person name="FitzGerald G.A."/>
<person name="McNamara P."/>
</authorList>
<dbReference type="PubMed" id="14645221"/>
<dbReference type="DOI" id="10.1074/jbc.m311973200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NPAS2; ARNTL/BMAL1 AND CLOCK</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="41477" last="41486">
<title>Site-specific acetylation of the fetal globin activator NF-E4 prevents its ubiquitination and regulates its interaction with the histone deacetylase, HDAC1.</title>
<authorList>
<person name="Zhao Q."/>
<person name="Cumming H."/>
<person name="Cerruti L."/>
<person name="Cunningham J.M."/>
<person name="Jane S.M."/>
</authorList>
<dbReference type="PubMed" id="15273251"/>
<dbReference type="DOI" id="10.1074/jbc.m405129200"/>
</citation>
<scope>INTERACTION WITH NFE4</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="2559" last="2563">
<title>The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases.</title>
<authorList>
<person name="Gangisetty O."/>
<person name="Lauffart B."/>
<person name="Sondarva G.V."/>
<person name="Chelsea D.M."/>
<person name="Still I.H."/>
</authorList>
<dbReference type="PubMed" id="14767476"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207424"/>
</citation>
<scope>INTERACTION WITH TACC1; TACC2 AND TACC3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Mol. Cell. Proteomics" volume="5" first="2072" last="2082">
<title>Modulation of testicular receptor 4 activity by mitogen-activated protein kinase-mediated phosphorylation.</title>
<authorList>
<person name="Huq M.D."/>
<person name="Gupta P."/>
<person name="Tsai N.P."/>
<person name="Wei L.N."/>
</authorList>
<dbReference type="PubMed" id="16887930"/>
<dbReference type="DOI" id="10.1074/mcp.m600180-mcp200"/>
</citation>
<scope>INTERACTION WITH NR2C2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="J. Cell. Biochem." volume="101" first="1252" last="1265">
<title>Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF.</title>
<authorList>
<person name="Shin S."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="17226766"/>
<dbReference type="DOI" id="10.1002/jcb.21250"/>
</citation>
<scope>INTERACTION WITH DDX17</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="2703" last="2708">
<title>Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5.</title>
<authorList>
<person name="Wiper-Bergeron N."/>
<person name="Salem H.A."/>
<person name="Tomlinson J.J."/>
<person name="Wu D."/>
<person name="Hache R.J."/>
</authorList>
<dbReference type="PubMed" id="17301242"/>
<dbReference type="DOI" id="10.1073/pnas.0607378104"/>
</citation>
<scope>INTERACTION WITH CEBPB</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="3718" last="3726">
<title>Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation.</title>
<authorList>
<person name="Pickard A."/>
<person name="Wong P.P."/>
<person name="McCance D.J."/>
</authorList>
<dbReference type="PubMed" id="20940255"/>
<dbReference type="DOI" id="10.1242/jcs.068924"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2016" name="J. Enzym. Inhib. Med. Chem." volume="31" first="75" last="82">
<title>P/CAF-mediated spermidine acetylation regulates histone acetyltransferase activity.</title>
<authorList>
<person name="Burgio G."/>
<person name="Corona D.F."/>
<person name="Nicotra C.M."/>
<person name="Carruba G."/>
<person name="Taibi G."/>
</authorList>
<dbReference type="PubMed" id="27389534"/>
<dbReference type="DOI" id="10.1080/14756366.2016.1205045"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="609" last="621">
<title>A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation.</title>
<authorList>
<person name="Zhu P."/>
<person name="Zhou W."/>
<person name="Wang J."/>
<person name="Puc J."/>
<person name="Ohgi K.A."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Glass C.K."/>
<person name="Rosenfeld M.G."/>
</authorList>
<dbReference type="PubMed" id="17707232"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.07.024"/>
</citation>
<scope>IDENTIFICATION IN A LARGE CHROMATIN REMODELING COMPLEX</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Mol. Endocrinol." volume="21" first="1847" last="1860">
<title>Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).</title>
<authorList>
<person name="Gururaj A.E."/>
<person name="Peng S."/>
<person name="Vadlamudi R.K."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="17505058"/>
<dbReference type="DOI" id="10.1210/me.2006-0514"/>
</citation>
<scope>INTERACTION WITH BCAS3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="Mol. Cell" volume="51" first="506" last="518">
<title>Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.</title>
<authorList>
<person name="Lin R."/>
<person name="Tao R."/>
<person name="Gao X."/>
<person name="Li T."/>
<person name="Zhou X."/>
<person name="Guan K.L."/>
<person name="Xiong Y."/>
<person name="Lei Q.Y."/>
</authorList>
<dbReference type="PubMed" id="23932781"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.07.002"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="13227" last="13227">
<title>KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification.</title>
<authorList>
<person name="Fournier M."/>
<person name="Orpinell M."/>
<person name="Grauffel C."/>
<person name="Scheer E."/>
<person name="Garnier J.M."/>
<person name="Ye T."/>
<person name="Chavant V."/>
<person name="Joint M."/>
<person name="Esashi F."/>
<person name="Dejaegere A."/>
<person name="Goenczy P."/>
<person name="Tora L."/>
</authorList>
<dbReference type="PubMed" id="27796307"/>
<dbReference type="DOI" id="10.1038/ncomms13227"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PLK4</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="10734" last="10734">
<title>SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing.</title>
<authorList>
<person name="Chen S."/>
<person name="Blank M.F."/>
<person name="Iyer A."/>
<person name="Huang B."/>
<person name="Wang L."/>
<person name="Grummt I."/>
<person name="Voit R."/>
</authorList>
<dbReference type="PubMed" id="26867678"/>
<dbReference type="DOI" id="10.1038/ncomms10734"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2017" name="J. Mol. Cell. Cardiol." volume="114" first="185" last="198">
<title>Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development.</title>
<authorList>
<person name="Ghosh T.K."/>
<person name="Aparicio-Sanchez J.J."/>
<person name="Buxton S."/>
<person name="Ketley A."/>
<person name="Mohamed T."/>
<person name="Rutland C.S."/>
<person name="Loughna S."/>
<person name="Brook J.D."/>
</authorList>
<dbReference type="PubMed" id="29174768"/>
<dbReference type="DOI" id="10.1016/j.yjmcc.2017.11.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TBX5</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3521" last="3532">
<title>Crystal structure of the histone acetyltransferase domain of the human PCAF transcriptional regulator bound to coenzyme A.</title>
<authorList>
<person name="Clements A."/>
<person name="Rojas J.R."/>
<person name="Trievel R.C."/>
<person name="Wang L."/>
<person name="Berger S.L."/>
<person name="Marmorstein R."/>
</authorList>
<dbReference type="PubMed" id="10393169"/>
<dbReference type="DOI" id="10.1093/emboj/18.13.3521"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 493-658 IN COMPLEX WITH COENZYME A</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1999" name="Nature" volume="399" first="491" last="496">
<title>Structure and ligand of a histone acetyltransferase bromodomain.</title>
<authorList>
<person name="Dhalluin C."/>
<person name="Carlson J.E."/>
<person name="Zeng L."/>
<person name="He C."/>
<person name="Aggarwal A.K."/>
<person name="Zhou M.-M."/>
</authorList>
<dbReference type="PubMed" id="10365964"/>
<dbReference type="DOI" id="10.1038/20974"/>
</citation>
<scope>STRUCTURE BY NMR OF 715-832</scope>
<scope>MUTAGENESIS OF VAL-752; TYR-760; TYR-802 AND TYR-809</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="Mol. Cell" volume="9" first="575" last="586">
<title>Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.</title>
<authorList>
<person name="Mujtaba S."/>
<person name="He Y."/>
<person name="Zeng L."/>
<person name="Farooq A."/>
<person name="Carlson J.E."/>
<person name="Ott M."/>
<person name="Verdin E."/>
<person name="Zhou M.-M."/>
</authorList>
<dbReference type="PubMed" id="11931765"/>
<dbReference type="DOI" id="10.1016/s1097-2765(02)00483-5"/>
</citation>
<scope>STRUCTURE BY NMR OF 719-832 IN COMPLEX WITH HIV-1 TAT</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="Cell" volume="149" first="214" last="231">
<title>Histone recognition and large-scale structural analysis of the human bromodomain family.</title>
<authorList>
<person name="Filippakopoulos P."/>
<person name="Picaud S."/>
<person name="Mangos M."/>
<person name="Keates T."/>
<person name="Lambert J.P."/>
<person name="Barsyte-Lovejoy D."/>
<person name="Felletar I."/>
<person name="Volkmer R."/>
<person name="Muller S."/>
<person name="Pawson T."/>
<person name="Gingras A.C."/>
<person name="Arrowsmith C.H."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="22464331"/>
<dbReference type="DOI" id="10.1016/j.cell.2012.02.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 715-831</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="942" last="946">
<title>A recurrent de novo mutation in ACTG1 causes isolated ocular coloboma.</title>
<authorList>
<consortium name="UK10K"/>
<person name="Rainger J."/>
<person name="Williamson K.A."/>
<person name="Soares D.C."/>
<person name="Truch J."/>
<person name="Kurian D."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Seawright A."/>
<person name="Prendergast J."/>
<person name="Halachev M."/>
<person name="Wheeler A."/>
<person name="McTeir L."/>
<person name="Gill A.C."/>
<person name="van Heyningen V."/>
<person name="Davey M.G."/>
<person name="FitzPatrick D.R."/>
</authorList>
<dbReference type="PubMed" id="28493397"/>
<dbReference type="DOI" id="10.1002/humu.23246"/>
</citation>
<scope>VARIANT GLY-130</scope>
</reference>
<comment type="function">
<text evidence="14 19 28 29 30 31 33 34 35 38">Functions as a histone acetyltransferase (HAT) to promote transcriptional activation (PubMed:8945521). Has significant histone acetyltransferase activity with core histones (H3 and H4), and also with nucleosome core particles (PubMed:8945521). Also acetylates non-histone proteins, such as ACLY, PLK4, RRP9/U3-55K and TBX5 (PubMed:9707565, PubMed:10675335, PubMed:27796307, PubMed:23932781, PubMed:26867678, PubMed:29174768). Inhibits cell-cycle progression and counteracts the mitogenic activity of the adenoviral oncoprotein E1A (PubMed:8684459). Acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators: NPAS2-ARNTL/BMAL1 and CLOCK-ARNTL/BMAL1 heterodimers (PubMed:14645221). Involved in heart and limb development by mediating acetylation of TBX5, acetylation regulating nucleocytoplasmic shuttling of TBX5 (PubMed:29174768). Acts as a negative regulator of centrosome amplification by mediating acetylation of PLK4 (PubMed:27796307). Acetylates RRP9/U3-55K, a core subunit of the U3 snoRNP complex, impairing pre-rRNA processing (PubMed:26867678). Also acetylates spermidine (PubMed:27389534).</text>
</comment>
<comment type="function">
<text evidence="18">(Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="30 35">
<text>acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-lysyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:45948"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:10731"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57287"/>
<dbReference type="ChEBI" id="CHEBI:57288"/>
<dbReference type="ChEBI" id="CHEBI:61930"/>
<dbReference type="EC" id="2.3.1.48"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="43">
<dbReference type="Rhea" id="RHEA:45949"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="30">
<text>acetyl-CoA + spermidine = CoA + H(+) + N(8)-acetylspermidine</text>
<dbReference type="Rhea" id="RHEA:28270"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57287"/>
<dbReference type="ChEBI" id="CHEBI:57288"/>
<dbReference type="ChEBI" id="CHEBI:57834"/>
<dbReference type="ChEBI" id="CHEBI:58535"/>
<dbReference type="EC" id="2.3.1.57"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="43">
<dbReference type="Rhea" id="RHEA:28271"/>
</physiologicalReaction>
</comment>
<comment type="activity regulation">
<text evidence="30">Activated in vitro by very low concentrations of spermidine, but inhibited at spermidine concentrations higher than 4 uM. The activating effect of low spermidine concentrations may be mediated by N(8)-acetylspermidine produced by KAT2B/P/CAF itself acting as a positive feedback loop.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="30">1.74 uM for acetyl-CoA</KM>
<KM evidence="30">2.29 uM for spermidine</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="9 14 16 17 19 20 21 22 23 24 25 26 31 33 34 36 37 38">Interacts with SIRT1. Interacts (unsumoylated form) with NR2C1; the interaction promotes transactivation activity (By similarity). Interacts with EP300, CREBBP and DDX17. Interacts with NCOA1 and NCOA3. Component of a large chromatin remodeling complex, at least composed of MYSM1, KAT2B/PCAF, RBM10 and KIF11/TRIP5. Interacts with NR2C2 (hypophosphorylated and unsumoylated form); the interaction promotes the transactivation activity of NR2C2. Interacts with KLF1; the interaction does not acetylate KLF1 and there is no enhancement of its transactivational activity. Interacts with NFE4. Interacts with MECOM. Interacts with E2F1; the interaction acetylates E2F1 augmenting its DNA-binding and transcriptional activity. Interacts with NPAS2, ARNTL/BMAL1 and CLOCK. Interacts with BCAS3. Interacts with CEBPB (PubMed:17301242). Interacts with NR4A3 (By similarity). Interacts with NFATC2 (By similarity). Interacts with TBX5 (PubMed:29174768). Interacts with PLK4 (PubMed:27796307). Interacts with RB1; this interaction leads to RB1 acetylation (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="18">(Microbial infection) Interacts with and acetylates HIV-1 Tat.</text>
</comment>
<comment type="subunit">
<text evidence="15">(Microbial infection) Interacts with HTLV-1 Tax.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-1001438">
<id>O60566</id>
<label>BUB1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-744366">
<id>Q96KQ7</id>
<label>EHMT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-9846663">
<id>Q9Y5W3</id>
<label>KLF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-477232">
<id>Q8IXJ6</id>
<label>SIRT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-712521">
<id>Q16594</id>
<label>TAF9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-1797287">
<id>Q15672</id>
<label>TWIST1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-1054489">
<id>P22415</id>
<label>USF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-1029979">
<id>P28033</id>
<label>Cebpb</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-866453">
<id>P03129</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-522090">
<id>P02299</id>
<label>His3:CG33854</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-185028">
<id>P84040</id>
<label>His4:CG33909</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-2338228">
<id>O88898-2</id>
<label>Tp63</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-2603114">
<id>P03255</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477430">
<id>Q92831</id>
</interactant>
<interactant intactId="EBI-6859460">
<id>P03255-2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="27 33">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="33">Cytoplasm</location>
<location evidence="33">Cytoskeleton</location>
<location evidence="33">Microtubule organizing center</location>
<location evidence="33">Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="27">Cytoplasm</location>
</subcellularLocation>
<text evidence="27 33">Mainly localizes to the nucleus. Also localizes to centrosomes in late G1 and around the G1/S transition, coinciding with the onset of centriole formation. Subcellular location may vary depending upon cell differentiation state. Cytoplasmic at the very stages of keratinocyte differentiation, becomes nuclear at later differentiation stages. Cytoplasmic in basal epithelial cells (undifferentiated cells) and nuclear in parabasal cells (differentiated cells) (PubMed:20940255).</text>
</comment>
<comment type="tissue specificity">
<text evidence="27 34">Ubiquitously expressed but most abundant in heart and skeletal muscle. Also expressed in the skin, in keratinocytes (at protein level) (PubMed:20940255).</text>
</comment>
<comment type="developmental stage">
<text evidence="27">Up-regulated during keratinocyte differentiation (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="17">(Microbial infection) The bromodomain mediates binding to HIV-1 Tat.</text>
</comment>
<comment type="disease">
<text evidence="32">Defects in KAT2B has been found in a patient with isolated coloboma, a defect of the eye characterized by the absence of ocular structures due to abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure). Isolated colobomas may be associated with an abnormally small eye (microphthalmia) or small cornea.</text>
</comment>
<comment type="similarity">
<text evidence="42">Belongs to the acetyltransferase family. GCN5 subfamily.</text>
</comment>
<dbReference type="EC" id="2.3.1.48" evidence="35"/>
<dbReference type="EC" id="2.3.1.57" evidence="30"/>
<dbReference type="EMBL" id="U57317">
<property type="protein sequence ID" value="AAC50890.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC060823">
<property type="protein sequence ID" value="AAH60823.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC070075">
<property type="protein sequence ID" value="AAH70075.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2634.1"/>
<dbReference type="PIR" id="S71788">
<property type="entry name" value="S71788"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003875.3">
<property type="nucleotide sequence ID" value="NM_003884.4"/>
</dbReference>
<dbReference type="PDB" id="1CM0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=493-658"/>
</dbReference>
<dbReference type="PDB" id="1JM4">
<property type="method" value="NMR"/>
<property type="chains" value="B=719-832"/>
</dbReference>
<dbReference type="PDB" id="1N72">
<property type="method" value="NMR"/>
<property type="chains" value="A=719-832"/>
</dbReference>
<dbReference type="PDB" id="1WUG">
<property type="method" value="NMR"/>
<property type="chains" value="A=719-832"/>
</dbReference>
<dbReference type="PDB" id="1WUM">
<property type="method" value="NMR"/>
<property type="chains" value="A=719-832"/>
</dbReference>
<dbReference type="PDB" id="1ZS5">
<property type="method" value="NMR"/>
<property type="chains" value="A=719-832"/>
</dbReference>
<dbReference type="PDB" id="2RNW">
<property type="method" value="NMR"/>
<property type="chains" value="A=719-832"/>
</dbReference>
<dbReference type="PDB" id="2RNX">
<property type="method" value="NMR"/>
<property type="chains" value="A=719-832"/>
</dbReference>
<dbReference type="PDB" id="3GG3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="4NSQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B/C/D=493-658"/>
</dbReference>
<dbReference type="PDB" id="5FDZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.22"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.08"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5FE9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5LVQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5LVR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="5MKX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.68"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDB" id="6J3O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A/B=715-831"/>
</dbReference>
<dbReference type="PDBsum" id="1CM0"/>
<dbReference type="PDBsum" id="1JM4"/>
<dbReference type="PDBsum" id="1N72"/>
<dbReference type="PDBsum" id="1WUG"/>
<dbReference type="PDBsum" id="1WUM"/>
<dbReference type="PDBsum" id="1ZS5"/>
<dbReference type="PDBsum" id="2RNW"/>
<dbReference type="PDBsum" id="2RNX"/>
<dbReference type="PDBsum" id="3GG3"/>
<dbReference type="PDBsum" id="4NSQ"/>
<dbReference type="PDBsum" id="5FDZ"/>
<dbReference type="PDBsum" id="5FE0"/>
<dbReference type="PDBsum" id="5FE1"/>
<dbReference type="PDBsum" id="5FE2"/>
<dbReference type="PDBsum" id="5FE3"/>
<dbReference type="PDBsum" id="5FE4"/>
<dbReference type="PDBsum" id="5FE5"/>
<dbReference type="PDBsum" id="5FE6"/>
<dbReference type="PDBsum" id="5FE7"/>
<dbReference type="PDBsum" id="5FE8"/>
<dbReference type="PDBsum" id="5FE9"/>
<dbReference type="PDBsum" id="5LVQ"/>
<dbReference type="PDBsum" id="5LVR"/>
<dbReference type="PDBsum" id="5MKX"/>
<dbReference type="PDBsum" id="6J3O"/>
<dbReference type="BMRB" id="Q92831"/>
<dbReference type="SMR" id="Q92831"/>
<dbReference type="BioGRID" id="114375">
<property type="interactions" value="197"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1004">
<property type="entry name" value="PCAF-containing ATAC complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-989">
<property type="entry name" value="PCAF histone acetylase complex"/>
</dbReference>
<dbReference type="CORUM" id="Q92831"/>
<dbReference type="DIP" id="DIP-29778N"/>
<dbReference type="IntAct" id="Q92831">
<property type="interactions" value="47"/>
</dbReference>
<dbReference type="MINT" id="Q92831"/>
<dbReference type="STRING" id="9606.ENSP00000263754"/>
<dbReference type="BindingDB" id="Q92831"/>
<dbReference type="ChEMBL" id="CHEMBL5500"/>
<dbReference type="DrugBank" id="DB08186">
<property type="generic name" value="(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB01992">
<property type="generic name" value="Coenzyme A"/>
</dbReference>
<dbReference type="DrugBank" id="DB08291">
<property type="generic name" value="N-(3-AMINOPROPYL)-2-NITROBENZENAMINE"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2737"/>
<dbReference type="CarbonylDB" id="Q92831"/>
<dbReference type="iPTMnet" id="Q92831"/>
<dbReference type="PhosphoSitePlus" id="Q92831"/>
<dbReference type="BioMuta" id="KAT2B"/>
<dbReference type="DMDM" id="83287776"/>
<dbReference type="REPRODUCTION-2DPAGE" id="Q92831"/>
<dbReference type="EPD" id="Q92831"/>
<dbReference type="jPOST" id="Q92831"/>
<dbReference type="MassIVE" id="Q92831"/>
<dbReference type="MaxQB" id="Q92831"/>
<dbReference type="PaxDb" id="Q92831"/>
<dbReference type="PeptideAtlas" id="Q92831"/>
<dbReference type="PRIDE" id="Q92831"/>
<dbReference type="ProteomicsDB" id="75508"/>
<dbReference type="Antibodypedia" id="3865">
<property type="antibodies" value="430 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000263754">
<property type="protein sequence ID" value="ENSP00000263754"/>
<property type="gene ID" value="ENSG00000114166"/>
</dbReference>
<dbReference type="GeneID" id="8850"/>
<dbReference type="KEGG" id="hsa:8850"/>
<dbReference type="UCSC" id="uc003cbq.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8850"/>
<dbReference type="DisGeNET" id="8850"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000114166.7"/>
<dbReference type="GeneCards" id="KAT2B"/>
<dbReference type="HGNC" id="HGNC:8638">
<property type="gene designation" value="KAT2B"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000114166">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="602303">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92831"/>
<dbReference type="OpenTargets" id="ENSG00000114166"/>
<dbReference type="PharmGKB" id="PA162392705"/>
<dbReference type="eggNOG" id="KOG1472">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154995"/>
<dbReference type="HOGENOM" id="CLU_015901_0_0_1"/>
<dbReference type="InParanoid" id="Q92831"/>
<dbReference type="KO" id="K06062"/>
<dbReference type="OMA" id="DFAIGYF"/>
<dbReference type="OrthoDB" id="349249at2759"/>
<dbReference type="PhylomeDB" id="Q92831"/>
<dbReference type="TreeFam" id="TF105399"/>
<dbReference type="BRENDA" id="2.3.1.48">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q92831"/>
<dbReference type="Reactome" id="R-HSA-1912408">
<property type="pathway name" value="Pre-NOTCH Transcription and Translation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2032785">
<property type="pathway name" value="YAP1- and WWTR1 (TAZ)-stimulated gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210744">
<property type="pathway name" value="Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2122947">
<property type="pathway name" value="NOTCH1 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2644606">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2894862">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214847">
<property type="pathway name" value="HATs acetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-350054">
<property type="pathway name" value="Notch-HLH transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5250924">
<property type="pathway name" value="B-WICH complex positively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578768">
<property type="pathway name" value="Physiological factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689901">
<property type="pathway name" value="Metalloprotease DUBs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73762">
<property type="pathway name" value="RNA Polymerase I Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8936459">
<property type="pathway name" value="RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941856">
<property type="pathway name" value="RUNX3 regulates NOTCH signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013508">
<property type="pathway name" value="NOTCH3 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013695">
<property type="pathway name" value="NOTCH4 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617629">
<property type="pathway name" value="Regulation of FOXO transcriptional activity by acetylation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q92831"/>
<dbReference type="BioGRID-ORCS" id="8850">
<property type="hits" value="1 hit in 881 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KAT2B">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q92831"/>
<dbReference type="GeneWiki" id="PCAF"/>
<dbReference type="GenomeRNAi" id="8850"/>
<dbReference type="Pharos" id="Q92831">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q92831"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="RNAct" id="Q92831">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000114166">
<property type="expression patterns" value="Expressed in corpus callosum and 243 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q92831">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031672">
<property type="term" value="C:A band"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042641">
<property type="term" value="C:actomyosin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005671">
<property type="term" value="C:Ada2/Gcn5/Ada3 transcription activator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031674">
<property type="term" value="C:I band"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000776">
<property type="term" value="C:kinetochore"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000125">
<property type="term" value="C:PCAF complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016407">
<property type="term" value="F:acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004861">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004145">
<property type="term" value="F:diamine N-acetyltransferase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004468">
<property type="term" value="F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061733">
<property type="term" value="F:peptide-lysine-N-acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription coregulator activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006338">
<property type="term" value="P:chromatin remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043970">
<property type="term" value="P:histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018393">
<property type="term" value="P:internal peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060173">
<property type="term" value="P:limb development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018076">
<property type="term" value="P:N-terminal peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046600">
<property type="term" value="P:negative regulation of centriole replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000233">
<property type="term" value="P:negative regulation of rRNA processing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018394">
<property type="term" value="P:peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045815">
<property type="term" value="P:positive regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045722">
<property type="term" value="P:positive regulation of gluconeogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045747">
<property type="term" value="P:positive regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007221">
<property type="term" value="P:positive regulation of transcription of Notch receptor target"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045652">
<property type="term" value="P:regulation of megakaryocyte differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010835">
<property type="term" value="P:regulation of protein ADP-ribosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.920.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00390"/>
<dbReference type="InterPro" id="IPR016181">
<property type="entry name" value="Acyl_CoA_acyltransferase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001487">
<property type="entry name" value="Bromodomain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036427">
<property type="entry name" value="Bromodomain-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018359">
<property type="entry name" value="Bromodomain_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR037800">
<property type="entry name" value="GCN5"/>
</dbReference>
<dbReference type="InterPro" id="IPR016376">
<property type="entry name" value="GCN5/PCAF"/>
</dbReference>
<dbReference type="InterPro" id="IPR000182">
<property type="entry name" value="GNAT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR009464">
<property type="entry name" value="PCAF_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR45750">
<property type="entry name" value="PTHR45750"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00583">
<property type="entry name" value="Acetyltransf_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00439">
<property type="entry name" value="Bromodomain"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF06466">
<property type="entry name" value="PCAF_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF003048">
<property type="entry name" value="Histone_acetylase_PCAF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00503">
<property type="entry name" value="BROMODOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00297">
<property type="entry name" value="BROMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47370">
<property type="entry name" value="SSF47370"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55729">
<property type="entry name" value="SSF55729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00633">
<property type="entry name" value="BROMODOMAIN_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50014">
<property type="entry name" value="BROMODOMAIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51186">
<property type="entry name" value="GNAT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0103">Bromodomain</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Histone acetyltransferase KAT2B" id="PRO_0000211208">
<location>
<begin position="1"/>
<end position="832"/>
</location>
</feature>
<feature type="domain" description="N-acetyltransferase" evidence="8 11">
<location>
<begin position="503"/>
<end position="651"/>
</location>
</feature>
<feature type="domain" description="Bromo" evidence="10 42">
<location>
<begin position="740"/>
<end position="810"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="13">
<location>
<begin position="574"/>
<end position="576"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="13">
<location>
<begin position="581"/>
<end position="587"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="13">
<location>
<begin position="612"/>
<end position="615"/>
</location>
</feature>
<feature type="active site" description="Proton donor/acceptor" evidence="39">
<location>
<position position="570"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with isolated coloboma; unknown pathological significance." id="VAR_079852" evidence="32">
<original>V</original>
<variation>G</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17006625." id="VAR_034372">
<original>N</original>
<variation>S</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetyl-lysine binding." evidence="12">
<original>V</original>
<variation>A</variation>
<location>
<position position="752"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetyl-lysine binding." evidence="12">
<original>Y</original>
<variation>A</variation>
<location>
<position position="760"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetyl-lysine binding." evidence="12">
<original>Y</original>
<variation>A</variation>
<location>
<position position="802"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of acetyl-lysine binding." evidence="12">
<original>Y</original>
<variation>A</variation>
<location>
<position position="809"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50890." ref="1" evidence="42">
<original>PP</original>
<variation>AA</variation>
<location>
<begin position="804"/>
<end position="805"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="494"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="509"/>
<end position="525"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="531"/>
<end position="538"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="543"/>
<end position="550"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="553"/>
<end position="563"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="564"/>
<end position="567"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="568"/>
<end position="576"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="578"/>
<end position="580"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="582"/>
<end position="584"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="585"/>
<end position="599"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="604"/>
<end position="609"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="611"/>
<end position="613"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="614"/>
<end position="618"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="619"/>
<end position="621"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="623"/>
<end position="625"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="630"/>
<end position="633"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="644"/>
<end position="649"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="727"/>
<end position="741"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="742"/>
<end position="744"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="746"/>
<end position="748"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="754"/>
<end position="756"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="757"/>
<end position="759"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="760"/>
<end position="763"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="764"/>
<end position="766"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="770"/>
<end position="778"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="785"/>
<end position="802"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="805"/>
<end position="807"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="808"/>
<end position="827"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="828"/>
<end position="830"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CM0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JM4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N72"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1WUG"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1WUM"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZS5"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5MKX"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q92830"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JHD1"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00035"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00532"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10365964"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10393169"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10675335"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10766811"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11568182"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11931765"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12486002"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645221"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14767476"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15273251"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16887930"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17226766"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17301242"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17505058"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17707232"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20940255"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23932781"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26867678"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27389534"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27796307"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28493397"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29174768"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8684459"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8945521"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9296499"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346901"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9707565"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10393169"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12486002"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="27796307"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000305"/>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27389534"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAC50890.2"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:8638"/>
</source>
</evidence>
<sequence length="832" mass="93013" checksum="72F516E8BC00CC0C" modified="2005-05-10" version="3">MSEAGGAGPGGCGAGAGAGAGPGALPPQPAALPPAPPQGSPCAAAAGGSGACGPATAVAAAGTAEGPGGGGSARIAVKKAQLRSAPRAKKLEKLGVYSACKAEESCKCNGWKNPNPSPTPPRADLQQIIVSLTESCRSCSHALAAHVSHLENVSEEEMNRLLGIVLDVEYLFTCVHKEEDADTKQVYFYLFKLLRKSILQRGKPVVEGSLEKKPPFEKPSIEQGVNNFVQYKFSHLPAKERQTIVELAKMFLNRINYWHLEAPSQRRLRSPNDDISGYKENYTRWLCYCNVPQFCDSLPRYETTQVFGRTLLRSVFTVMRRQLLEQARQEKDKLPLEKRTLILTHFPKFLSMLEEEVYSQNSPIWDQDFLSASSRTSQLGIQTVINPPPVAGTISYNSTSSSLEQPNAGSSSPACKASSGLEANPGEKRKMTDSHVLEEAKKPRVMGDIPMELINEVMSTITDPAAMLGPETNFLSAHSARDEAARLEERRGVIEFHVVGNSLNQKPNKKILMWLVGLQNVFSHQLPRMPKEYITRLVFDPKHKTLALIKDGRVIGGICFRMFPSQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKHDILNFLTYADEYAIGYFKKQGFSKEIKIPKTKYVGYIKDYEGATLMGCELNPRIPYTEFSVIIKKQKEIIKKLIERKQAQIRKVYPGLSCFKDGVRQIPIESIPGIRETGWKPSGKEKSKEPRDPDQLYSTLKSILQQVKSHQSAWPFMEPVKRTEAPGYYEVIRFPMDLKTMSERLKNRYYVSKKLFMADLQRVFTNCKEYNPPESEYYKCANILEKFFFSKIKEAGLIDK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

